The literature on GPCR (G-protein-coupled receptor) homooligomerization encompasses conflicting views that range from interpretations that GPCRs must be monomeric, through comparatively newer proposals that they exist as dimers or higherorder oligomers, to suggestions that such quaternary structures are rather ephemeral or merely accidental and may serve no functional purpose. In the present study we use a novel method of FRET (Förster resonance energy transfer) spectrometry and controlled expression of energy donor-tagged species to show that M 3 Rs (muscarinic M 3 acetylcholine receptors) at the plasma membrane exist as stable dimeric complexes, a large fraction of which interact dynamically to form tetramers without the presence of trimers, pentamers, hexamers etc. That M 3 R dimeric units interact dynamically was also supported by co-immunoprecipitation of receptors synthesized at distinct times. On the basis of all these findings, we propose a conceptual framework that may reconcile the conflicting views on the quaternary structure of GPCRs.
INTRODUCTION
GPCRs (G-protein-coupled receptors) are the largest family of transmembrane proteins in the human genome and the most utilized as the targets for small-molecule drugs and medicines [1] . Recently, a series of atomic level X-ray structures of members of the large class of rhodopsin-like GPCRs [2] [3] [4] [5] [6] [7] has appeared to provide support for the historical view, on the basis of analysis of the binding of such drugs, that these receptors exist as monomeric non-interacting polypeptides. Despite this, there has been persistent reports in the literature consistent with GPCRs existing as dimers or higher-order oligomers [8, 9] . Gratifyingly for champions of this proposal, X-ray structures of CXCR4 (CXC chemokine receptor 4) have provided strong evidence of a substantial dimer interface involving elements of transmembrane domains V and VI [10] . Moreover, the structure of the μ-opioid receptor shows a dimeric 4-helix bundle interface provided by many of the residues of transmembrane domains V and VI as well as a further, less extensive, interface provided by elements of transmembrane domains I and II along with the intracellular element often designated 'helix VIII' [11] . These interfaces potentially allow the presence of tetrameric or even higher-order organization [11] and suggest that at least a subset of the rhodopsin-like GPCRs form quaternary structures with avidity sufficient to be maintained throughout detergent-mediated solubilization and preparation for crystallization trials.
Support for the presence of GPCR dimers and/or higher-order quaternary complexes in intact cells and tissues has been derived from studies involving techniques ranging from fluorescence recovery after photobleaching [12] to approaches employing resonance energy transfer [13] [14] [15] [16] . Despite this, the functional significance of GPCR quaternary structure remains uncertain, although a substantial number of studies have shown the importance of dimeric/oligomeric interactions for the proper maturation and cellsurface delivery of class A receptors [17] [18] [19] and are consistent with interactions occurring at an early stage in GPCR synthesis.
Although certain commentators have championed the primacy of monomeric or oligomeric forms of rhodopsin-like GPCRs [20, 21] , it is not obvious that a single state must exist at the exclusion of others. Studies based on fluorescence recovery after photobleaching and antibody-based tethering of a GPCR have provided evidence for dynamic interactions between individual protomers, and for a varying extent of interaction between even closely related class A GPCRs [12] . Furthermore, studies that have begun to develop single-molecule tracking have provided evidence of the association and disassociation of what appear to be GPCR quaternary complexes [21] [22] [23] . In the present study we have assessed this hypothesis in cells engineered to express a form of the M 3 R (muscarinic M 3 acetylcholine receptor) tagged with an energy acceptor to remain at a constant amount, whereas levels of an energy donor-tagged form of a mutationally modified version of this receptor (Y149C/A239GM 3 R) could be titrated from an inducible locus [24] . Specifically, we investigated the quaternary organization and degree of stability of M 3 R at the plasma membrane. This was achieved by using measurement and analysis within a suitable theoretical framework [25, 26] of distributions of apparent FRET (Förster resonance energy transfer) efficiencies, E app (or E app histograms), across FRET images of individual cells expressing proteins of interest [15] . The quaternary structure of the complex was identified from the number and relative disposition of peaks within an E app histogram, which constitutes a veritable 'FRET spectrum' associated with a specific quaternary structure. The separation of dimer from tetramer signals is achieved using a method introduced in the present study that takes into account the amplitudes of the individual peaks in the E app histogram. Data analysis indicates that, at the plasma membrane, homomers of the M 3 R exist as a mixture of dimers and rhombic tetramers, whereas biochemical studies support dynamic interchanges between such complexes.
EXPERIMENTAL Cell models
Flp-In TM T-REx TM -293 cells constitutively expressing FLAG-M 3 R-Citrine and also harbouring Myc-Y149C/A239GM 3 RCerulean at the Flp-In TM T-REx TM locus were generated as described previously [24] . Cells were grown in DMEM (Dulbecco's modified Eagle's medium) without sodium pyruvate, supplemented with 10 % organic FBS (fetal bovine serum; PAA Laboratories), 2 mM L-glutamine, 1 % penicillin/streptomycin, 10 μg/ml blasticidin, 200 μg/ml hygromycin B and 1 mg/ml G418. Equivalent cells able to express either FLAG-M 3 R-Citrine or Myc-Y149C/A239GM 3 R-Cerulean in isolation from the FlpIn TM T-REx TM locus were generated and maintained in the same way, but without G418. Cell lines were maintained at 37
• C in a humidified environment with 5 % CO 2 . At 72 h prior to imaging, the cells were subcultured and seeded at 48 000-60 000 cells/cm 2 . The cells were approximately 70 % confluent after 48 h of growth, at which time fresh medium, containing doxycycline at the concentrations indicated in the Results section, was added to the cells for an additional 24 h incubation. The cells were then nonenzymatically lifted using Cellstripper (Mediatech) and resuspended in 1 ml of Opti-MEM medium (Life Technologies) for imaging.
Cell-surface biotinylation
Cells were seeded on to plates previously coated with poly-Dlysine and washed with ice-cold borate buffer (10 mM boric acid, 154 mM NaCl, 7.2 mM KCl and 1.8 mM CaCl 2 , pH 9.0) and incubated on ice with 1 ml of 0.8 mM EZ-Link sulphosuccinimidyl 2-(biotinamido)ethyl-1,3-dithiopropionate (Pierce Chemical) in borate buffer for 15 min. The cells were then rinsed with a solution of 0.192 M glycine and 25 mM Tris, pH 8.3, to quench the excess biotin, and lysed with RIPA buffer (50 mM Hepes, 150 mM NaCl, 1 % Triton X-100, 00.5 % sodium deoxycholate, 10 mM NaF, 5 mM EDTA, 10 mM NaH 2 PO 4 and 5 % ethylene glycol, pH 7.4). Lysates were centrifuged for 30 min at 14 000 g, and the supernatant was recovered. Cell-surface biotinylated proteins were isolated using 50 μl of ImmunoPure immobilized streptavidin (Pierce Chemical) and rotation for 1 h at 4
• C. Samples were subsequently centrifuged, and the streptavidin beads were washed three times with RIPA buffer. Finally, the biotinylated proteins were eluted with 50 μl of SDS sample buffer for 1 h at 37
• C, and SDS/PAGE and Western blotting were performed.
Cell lysate SDS/PAGE and immunoblotting
Cells were washed once in ice-cold PBS and harvested with ice-cold RIPA buffer supplemented with Complete TM Protease
Inhibitor Cocktail (Roche). Extracts were passed through a 25-gauge needle and incubated for 15 min at 4 • C while spinning on a rotating wheel. Cellular extracts were then centrifuged for 30 min at 14 000 g and the supernatant was recovered. Samples were heated at 65
• C for 15 min and subjected to SDS/PAGE analysis using 4-12 % BisTris gels (NuPAGE; Life Technologies) and Mops buffer. Proteins were then electrophoretically transferred on to nitrocellulose membranes that were blocked for 45 min in 5 % (w/v) non-fat dried skimmed milk powder in TBST [Tris-buffered saline (50 μM Tris and 150 μM NaCl, pH 7.6) containing 0.1 % Tween 20] and subsequently incubated with the required primary antibody overnight at 4
• C. Incubation with the appropriate horseradish-peroxidase-linked IgG secondary antiserum was performed for 2 h at room temperature (22 • C). Immunoblots were developed by application of an enhanced chemiluminescence substrate (Pierce).
PLA (proximity ligation assay)
Cells were seeded on 0-thickness glass cover slips previously coated with poly-D-lysine. PLA [27] was performed on cells maintained with or without doxycycline induction using the Duolink II Detection Kit (Olink Biosicences). The antibodies used in the present study were monoclonal mouse anti-FLAG M2 and rabbit anti-FLAG antibodies (Sigma-Aldrich), and 9B11 mouse anti-Myc and rabbit anti-Myc antibodies (Cell Signaling Technology).
Two-photon fluorescence microscopy
Approximately 10 μl of a suspension of cells in Opti-MEM medium was placed on a microscope slide and covered with a coverslip. A SR-TPM (spectrally resolved two-photon microscope) was used to acquire the spectral images as described previously [15] . Briefly, a femtosecond Ti:Sapphire laser (KM Labs) was used as the excitation energy source. Laser pulses with spectra approximately 20 nm wide (full-width half-maximum) were focused through an infinity-corrected oilimmersion Plan Apochromat objective (×100 magnification, numerical aperture = 1.4; Nikon Instruments) to a diffractionlimited spot on to the sample. The back-propagating fluorescence emitted by the sample was projected through a transmission grating on to a cooled EMCCD (electron-multiplying chargecoupled-device camera; Andor, iXon 897).
Elementary emission spectra for the FRET pair
Cells harbouring Myc-Y149C/A239GM 3 R-Cerulean or FLAG-M 3 R-Citrine and induced with 100 ng/ml doxycycline were imaged with the SR-TPM using a light excitation of 800 nm. Average powers of the order of 35 mW and 60 mW (measured before the scanning head of the microscope) were used for Cerulean and Citrine respectively. The average emission spectra obtained from several cells were normalized to obtain elementary emission spectra of donor (D, Cerulean) and acceptor (A, Citrine). Owing to the negligible Citrine excitation by the 800 nm laser light (note that Citrine has single photon absorption wavelength at 516 nm [28] ), the Citrine emission was very dim even at comparatively higher excitation power. Therefore its spectrum contained cellular autofluorescence in the lower wavelength region. In order to correct for this artefact, the measured spectrum was fitted with three Gaussian functions, namely a broad Gaussian at lower wavelengths corresponding to cellular autofluorescence, and two other closely spaced Gaussians corresponding to the two spectral components usually seen in Citrine emission, were used to fit the measured spectrum of cells expressing FLAG-M 3 RCitrine. After the fitting, the first Gaussian was subtracted from the total measured spectrum to obtain the autofluorescence corrected emission spectrum of Citrine. For cross-checking, the emission spectrum of Citrine was also measured using a similar spectrallyresolved two-photon microscope equipped with a Ti:Sapphire laser (Tsunami, Spectra Physics) tuned to ∼900 nm wavelength.
Image analysis
Spectral images obtained from cells co-expressing inducible Myc-Y149C/A239GM 3 R-Cerulean and constitutive FLAG-M 3 R-Citrine that had been treated with different concentrations of doxycycline were unmixed using the D and A elementary spectra, determined as described above, to obtain the donor fluorescence intensity in presence of acceptor (k DA ) and the acceptor fluorescence intensity in presence of donor (k AD ) at every pixel of the imaged section of the cell [15, 26] . The spatial distribution map of FRET efficiencies was computed from the k DA and k AD values by using the following equation:
where w D and w A are the integrals of the normalized donor and acceptor spectra respectively, Q D (= 0.62) is the quantum yield of the donor [29] , and Q A (= 0.76) is the quantum yield of the acceptor [28] . E app distributions (i.e. the number of pixels showing a certain FRET efficiency value), or histograms, were computed by binning the apparent FRET efficiency values of all pixels (bin size, 0.01) and plotting their histograms. Only the pixels in the regions of interest around the cellular membrane were included in the analysis. To reduce the probability that pixels characterized only by instrumental noise contribute to the distribution of FRET efficiencies, a threshold value was used for the k DA and k AD images. The expression level of donor-tagged M 3 R was determined by comparing the measured fluorescence intensity of the donor corrected for FRET to the fluorescence emission of a standard fluorescent solution of purified YFP (yellow fluorescent protein; prepared as described previously [30] ), on the basis of the knowledge of absorption cross sections and the quantum yields of the two fluorophores [31, 32] .
All the procedures related to spectral unmixing, as well as computation of FRET efficiencies and donor-only fluorescence intensities were computer-coded using MatLab (The MathWorks).
Fitting of FRET efficiency distributions to quaternary structure models
The E app histograms obtained as described above were simulated with various quaternary structure models using Microsoft Excel. The best fit of the model to the experimental data was achieved by minimizing the fitting residual defined as:
where 'Experimental' stands for the experimentally observed number of occurrences of a certain FRET efficiency value (plotted on the vertical axis in the histograms), 'Simulated' is the simulated value for the 'Experimental' data and 'i' is a summation index corresponding to individual data points. The bar chart representing the average areas under the peaks in the histograms at a certain doxycycline concentration were fitted with the simulated rhombus tetramer model by minimizing the following fitting residual:
where 'j' is the bar number in the graph ( j = 1,3,4,5, i.e., starting from left and excluding the second peak), 'Experimental j ' is the height of a certain bar, 'j', which represents the average cumulative area under the Gaussian corresponding to the j th peak for all the cells and 'Simulated j ' represents the predicted height for each bar, according to the model described in the caption of Figure 3 .
RESULTS

Determination of the largest quaternary structure of M 3 R at the plasma membrane
We have generated previously [24] Flp-In TM T-REx TM -293 cells to constitutively express an N-terminally FLAG epitopetagged form of the human M 3 R that had the YFP Citrine linked in-frame to its C-terminal tail (FLAG-M 3 R-Citrine). These cells also harbour at the Flp-In TM T-REx TM locus an Nterminally Myc epitope-tagged form of the M 3 R with the cyan fluorescent protein Cerulean at the C-terminus and in which the ligand-binding pocket had been engineered by mutation of two residues to allow selective activation by the synthetic chemical CNO (clozapine N-oxide) rather than the natural ligand acetylcholine (Myc-Y149C/A239GM 3 R-Cerulean). The Flp-In TM T-REx TM locus allows expression of different amounts of Myc-Y149C/A239GM 3 R-Cerulean (i.e. donor) to be achieved following addition of various concentrations of the inducer doxycycline while levels of FLAG-M 3 R-Citrine remain constant [24] . Despite defining the presence of M 3 R homomers in these cells upon induction of Myc-Y149C/A239GM 3 R-Cerulean, previous studies were unable to effectively assess the location, the size of such complexes or their stability over time [24] . This cell line therefore provided a direct link to the previous work, whereas the pharmacological selectivity of the wild-type and variant form of the M 3 R allowed potential selective activation of the component parts of the multimers identified (see below).
To probe oligomerization of M 3 R at the cell surface, we used an optical microspectroscopic technique and FRET for probing interactions with pixel resolution [15] . This method provides distributions of FRET efficiencies for individual cells (rather than average values), avoids information washing caused by diffusion of molecules during the measurements, and is nearly insensitive to stochastic (or bystander) FRET [21] , which only introduces a low broad background in the FRET efficiency distributions [33] .
Initially, individual Flp-In TM T-REx TM -293 cell lines with induced expression of only Myc-Y149C/A239GM 3 R-Cerulean (energy donor) or only FLAG-M 3 R-Citrine (energy acceptor) were imaged to determine the elementary spectra of donors and acceptors. These elementary spectra were used to unmix spectrally resolved images of cells expressing both donors and acceptors to obtain donor fluorescence intensity in the presence of acceptors (k DA ) and acceptor fluorescence intensity in the presence of donors (k AD ), as described in the Experimental section. Co-expression of differing ratios of Myc-Y149C/A239GM 3 R-Cerulean and FLAG-M 3 R-Citrine was accomplished by inducing these cells for 24 h in the presence of different concentrations of doxycycline. image pixels according to their value (bin size, 0.01) and plotting the number of pixels in each bin against E app ( Figure 1C) .
The E app histograms obtained were incompatible with the oligomeric form of the M 3 R being a simple dimer, for which a single peak is expected in the histogram (however, please see the Discussion section). The E app histogram for the plasma membrane area of the cell was analysed using a FRET theory [25] for oligomeric complexes with various sizes and geometries [15, 26] . Figure 1(C) shows the results of a simulation using the parallelogram (or rhombus) tetramer model illustrated in Figure 1 (B). The pair-wise FRET efficiency, characterizing the energy transfer in a single donor and acceptor pair (E p ), was used as an adjustable parameter which simultaneously determines the positions of the five Gaussian peaks in the experimental data. As seen in Figure 1 (C), the rhombus tetramer properly describes the peaks in the E app histogram of the complexes localized at the cell surface. Simulations using a rhombus hexamer model (described in Supplementary Figure S1 at http://www.biochemj. org/bj/452/bj4520303add.htm) provided similarly good fits. However, of the twenty different peaks predicted by the hexamer model, only those peaks that have the same positions as obtained from the simulations with a tetramer were needed to achieve a good unique fit. That means that, in fact, the rhombus tetramer is the natural result of attempts to fit the data using higher order oligomers.
Flp-In TM T-REx TM -293 cells grown on glass coverslips and induced or not to express Myc-Y149C/A239GM 3 R-Cerulean demonstrated the presence of a substantial proportion of FLAG-M 3 R-Citrine at or close to the cell surface in both situations, and the appearance of Myc-Y149C/A239GM 3 R-Cerulean at a similar location only in doxycycline-induced cells. Merging of such images demonstrated the co-localization of the two forms of M 3 R at the level of light microscopy ( Figure 2 ). To ensure that these two forms of M 3 R were actually at the plasma membrane with the N-terminal region located extracellularly, and potentially participating in an oligomeric complex, we employed PLAs using anti-Myc and anti-FLAG antibodies as the primary detection agents. These also confirmed that the two forms of M 3 R were in close apposition, and the specificity of the PLA was confirmed by a lack of signal in cells in which expression of Myc-Y149C/A239GM 3 R-Cerulean had not been induced (Figure 2) .
In light of all these findings, and with the application of Occam's razor, we hypothesize that the rhombus tetramer is the largest quaternary structure formed by M 3 Rs at the plasma membrane. Separate control experiments, which incorporated FRET standards, confirmed that the detected oligomers are not artefacts potentially introduced by the methods of the present study [15, 34, 35] . Do tetramers represent the only quaternary structure at the plasma membrane?
Next, we assessed whether smaller structures (such as dimers and trimers) may coexist with tetramers. By inducing the cells with different doxycycline concentrations (0.5 ng/ml, 1.0 ng/ml, 10.0 ng/ml and 100 ng/ml), differing ratios of Myc-Y149C/A239GM 3 R-Cerulean and FLAG-M 3 R-Citrine concentrations were achieved in the cells. At least 30 cells for each doxycycline concentration were imaged and their E app histograms were analysed using the method described above. The areas under each individual Gaussian (with dimensions of pixels×percentage of E app or, simply, pixels) were averaged over all the cells treated with a certain doxycycline concentration, and a bar chart showing such averages for each peak in the histogram was created for each doxycycline concentration (Figure 3) . Each bar in the chart therefore represents the average number per cell of certain configurations of donors and acceptors in Figure 1(B) .
Assuming first that the oligomers are exclusively in tetrameric form, the heights of the individual bars in each chart were modelled using a set of mathematical expressions that depend on the number of different permutations within each of the tetrameric configurations shown in Figure 1 (B) (e.g. two for the first configuration, two for the second and four for the third) as well as the fraction of donor and acceptor concentrations in the tetramers (see the caption to Figure 3 ). As seen, the simulated bar heights were in agreement with the experimentally determined heights, except for the second bar (corresponding to the second peak in the E app histograms), for which the experimental value exceeded the theoretical prediction by a significant amount. We also note that the ratio between donor and acceptor concentrations (see the values in the caption of Figure 3 ) increases with an increase in doxycycline concentration, as expected for an increase in donor expression level. This speaks strongly in favour of the validity of the rhombus tetramer model used to analyse the E app histograms, because extraction of the correct donor-to-acceptor ratio confirms the validity of the mathematical expressions of the amplitudes predicted by the rhombus tetramer. The same conclusion may be drawn by simply noticing that the amplitudes of peaks 1 and 2 increase with an increase in donor expression level, whereas the amplitudes of peaks 4 and 5 decrease, as expected for a rhombus tetramer in which the proportion of the tetramer configurations rich in donors increases with donor expression level at the expense of the configurations rich in acceptors.
The excess in the cumulative amplitudes corresponding to the second peak suggests that an additional population of complexes must be present, which is characterized by only one peak in its E app histogram whose position is determined by the same pairwise FRET efficiency (E p ) as for the tetramers. The only possible explanation for the observed excess in the area of the second peak of the E app histogram appears to be the coexistence of dimers with tetramers at the membrane. Since trimers should contribute not only to the second but also to the fourth peak [26] in the experimentally determined histogram, we conclude that trimers are absent from our system. Overall, these observations suggest that the dimers and tetramers may dynamically interconvert at the plasma membrane. We will return to this idea below.
Having established the identity of the oligomeric structures present at the plasma membrane, we next used the observed excess in the height of the second bar in the charts (relative to the prediction by the tetramer model) to determine the ratio between the number of protomers associated into dimers with mixed composition (i.e. with both donor-and acceptor-tagged receptors) against those in tetramers with mixed composition. This was computed as the ratio between the excess height (i.e. experimental minus predicted value) of the second bar times two (because a dimer contains two protomers) and the sum of the heights of the five simulated bars in the individual charts multiplied by four (because each tetramer contains four protomers). The results corresponding to the four panels in Figure 3 are, in order from 3(A) to 3(D), 0.11, 0.10, 0.09 and 0.08.
Beyond a desire to use the same cell lines that had been used previously to define that M 3 R formed some element of quaternary structure [24] , the combination of wild-type and the mutationally modified M 3 R in these cells allowed distinct and independent estimates of the levels of expression of the receptors in these studies. Specific radioligand binding using [ 3 H]QNB (quinuclidinyl benzilate) allowed the selective measurement of the acceptor species (FLAG-M 3 R-Citrine), as this ligand does not bind with high affinity to Myc-Y149C/A239GM 3 RCerulean [24] , and this was complemented by determination of the expression level of donor-tagged receptor, which was based on microspectroscopic measurements. On the basis of determinations of the donor fluorescence intensity corrected for loss through FRET, as described in the Supplementary Online Data (at http://www.biochemj.org/bj/452/bj4520303add.htm), in the present study we estimated the donor to be present to between 1×10 5 and 2.5×10 5 molecules per cell for doxycycline concentrations ranging from 0.5 to 100 ng/ml (see the Supplementary Online Data). The ratios of donor to acceptor concentrations determined from fitting the bar chart for peak areas (Figure 3) , together with the determined concentrations of donors, allowed us to estimate the concentrations of acceptors, which varied between 2×10 5 and 7×10 4 molecules per cell as the doxycycline concentration was changed between 0.5 and 100 ng/ml. Importantly, these values are very similar to the number of acceptor-tagged copies per cell (∼2×10 5 ) determined from binding of the highly-specific [ 3 H]QNB ligand to the acceptor (FLAG-M 3 R-Citrine) in the absence of doxycycline. The total expression level of receptor was approximately 3×10 5 receptors per cell, almost independent of doxycycline concentration. This is consistent with the almost constant ratio of dimer to tetramer concentration (see above).
Quaternary structure of M 3 R at the plasma membrane in the presence of agonists
In separate experiments, we took batches of cells induced by 10 ng/ml of doxycycline to coexpress both forms of the receptor and separated them into three aliquots: one sample was treated with CNO (100 μM for 5-20 min), which acts as a highly selective agonist for Myc-Y149C/A239GM 3 R-Cerulean [24, 36] , another sample was treated with carbachol (100 μM), a stable mimetic of the natural M 3 R ligand acetylcholine, whereas an untreated one was used as a control. We imaged the cells as described above and then analysed the E app histograms using the rhombus tetramer model shown in Figure 1(B) . The E p values obtained for various cells treated with ligand fell in the same range of values as that corresponding to the untreated cells; this suggested that both the global geometry of the complexes and the distances between their protomers remain largely unaffected upon binding of an agonist ligand. Next, we generated bar charts by adding together the average areas under the Gaussian peaks (Supplementary Figure  S2 at http://www.biochemj.org/bj/452/bj4520303add.htm) and determined the ratios of protomer concentrations in dimers and tetramers from the excess in height of peak 2 in the bar chart (see above for details of this procedure), which were 0.16, 0.09 and 0.09 for carbachol-treated, CNO-treated and untreated cells respectively.
Owing to the variability of this ratio (from 0.09 to 0.15) observed in several experiments even in the absence of ligand, at this time we chose not to assign any significance to the slight differences between the partitions of protomers among dimers and tetramers in the presence and absence of the selective agonist ligands. The precise interpretation of these results is further complicated by the fact that although saturation binding experiments indicate that the wild-type M 3 receptor binds CNO with an affinity of ∼15 μM (see Table S1 in [37] ), the receptor does not generate a response to this concentration of CNO (see Figure 1 in [36] ). More detailed experiments would need to be conducted in the future to more clearly determine whether ligand binding has a significant effect on the dimer/oligomer fraction.
Testing the stability of the oligomeric complexes
Since our FRET measurements suggested that M 3 Rs form rhombus-shaped tetramers as well as dimers at the plasma membrane, we hypothesized that tetramers of M 3 R may be meta-stable complexes, although it is widely accepted that oligomeric organization is initiated during the processes of protein synthesis and maturation [19] . We used co-immunoprecipitation studies to assess whether recently synthesized receptors would rapidly form stable oligomeric complexes, or whether such complexes might represent transient species that can interchange. To do so, we took advantage of the ability of treatment of cells with the de novo N-glycosylation inhibitor tunicamycin to allow the separate identification of recently synthesized and longer lived copies of M 3 R. Initially, to ensure that elimination of N-glycosylation did not prevent cell surface delivery of the M 3 R, untreated and tunicamycin-treated cells that were induced to express Myc-Y149C/A239GM 3 R-Cerulean were subjected to biotinylation to identify cell surface receptor proteins. Biotinylated proteins were isolated and then resolved by SDS/PAGE. Detection of biotinylated anti-Myc immunoreactivity in samples from both untreated (110 kDa) and tunicamycintreated (90 kDa) cells defined whether the receptor had been present at the cell surface. The observed ratio of biotinylated N-glycosylated and non-glycosylated M 3 R was similar to their proportions in total cell lysates ( Figure 4A) ; this indicated that prevention of N-glycosylation does not interfere with cell surface delivery of this receptor. Myc-Y149C/A239GM 3 R-Cerulean was then immunoprecipitated from cells that were concurrently doxycycline-induced and tunicamycin-treated. Following SDS/PAGE, immunoblotting such samples with anti-FLAG identified both non-glycosylated and N-glycosylated forms of FLAG-M 3 R-Citrine associated with Myc-Y149C/A239GM 3 R-Cerulean ( Figure 4B ).
On the basis of the experiments above, the presence of the N-glycosylated form in anti-Myc immunoprecipitates must reflect a complex that now contains a FLAG-tagged form of the receptor synthesized prior to the induction of expression of Myc-Y149C/A239GM 3 R-Cerulean. As both forms of the FLAG-tagged receptor are immunoprecipitated with an anti-Myc antibody this demonstrates that induced Myc-Y149C/A239GM 3 R-Cerulean protomers are present in complexes synthesized at different times. Thus these results confirm that the oligomeric nature of the complexes is nonpermanent, and that the dimers and tetramers can interconvert. 
DISCUSSION
The M 3 R exists as a mixture of dimers and tetramers at the cell surface By coexpressing different ratios of Myc-Y149C/A239GM 3 RCerulean and FLAG-M 3 R-Citrine in living cells and using spectrally resolved FRET, we determined apparent FRET efficiency (E app ) histograms, reflecting oligomers of these forms of M 3 R located in regions at or near the plasma membrane. The broad histograms obtained were rich in information that could only be defined by organization of the M 3 R within a rhombic tetramer and were incompatible with the oligomeric form of the M 3 R being limited to a simple dimer, for which a single peak is expected [15, 26] . By using this method to analyse data from numerous cells expressing donor-tagged receptors at various levels, the computed areas under each individually described Gaussian were averaged over all cells, and bar charts displaying the average number of oligomers corresponding to each of the five anticipated donor-acceptor configurations of a rhombus tetramer were created for each of the four donor expression levels. We modelled the expected contributions of the component bars using a simple model that takes into account the ratio between donor and acceptor concentrations, and this was subsequently compared with the experimental data. This ratio was observed to increase with increasing doxycycline concentrations, as expected for an increase in donor expression level. This provided further support to our observation that the largest quaternary structure of M 3 R at the plasma membrane was a rhombus tetramer.
Despite this, the analyses of the experimental data clearly indicated a marked excess in the amplitude of the second peak in the E app histogram compared with that anticipated if the oligomeric M 3 R existed solely as a rhombic tetramer. This experimental excess could only be accounted for in models that allow dimers, but not trimers or other oligomeric sizes, to also be present. In support of dynamic interconversion between such oligomeric states over time, co-immunoprecipitation assays suggested that receptors synthesized at different times can be detected in the same oligomer and, therefore, that such complexes are transient in nature and able to interchange protomers. Furthermore, by extension, the absence of M 3 R trimers in the plasma membrane as indicated by the E app histogram data implies that protomers do not associate into tetramers one at a time, but rather as dimeric pairs. These observations lead to the conclusion that the molecular bonds within dimers are probably rather strong and suggest that no species with an odd number of protomers are likely to exist under physiological conditions; this excludes both monomers and trimers from the mix. Clearly, non-covalent bonds between the protomers of a receptor dimer can be broken, as a range of studies have produced and purified monomeric GPCRs for both biophysical and biochemical analysis [38, 39] . Despite this, our results suggest for the first time that dimers may be the smallest structural unit in which M 3 Rs exist at the plasma membrane, and that the dimers associate reversibly to form tetramers. No direct evidence for hexamers or further higher-order oligomers was obtained in the present study. This may indicate that the tetramer is the highest-order structure of the M 3 R.
Although our interpretation of the data as presented above appears to be self-consistent, one could, in principle, argue that combinations of dimers and free donors (or donor-only dimers) in our samples may have given the appearance of a combination of dimers and rhombus-shaped tetramers. This possibility, although often mentioned in discussions on this topic, is actually rather easily dismissed. Numerical simulations previously performed by some of the authors of the present study did indeed indicate that the presence of non-interacting free donors in the same excitation volume with a mixed dimer composed of a donor and an acceptor leads to a reduction in the amplitude of the dimer peak in the E app histogram and an appearance of a broader distribution of FRET efficiencies towards values lower than those of the dimer [33] . However, no clearly individualized peak (apart from that of the dimer) emerged from those simulations, and the rather amorphous distribution of FRET efficiencies observed at values lower than that of the dimer ended abruptly on the upper end of the E app scale. These features are at a variance with the histograms obtained in the present study which show multiple peaks whose amplitudes decrease gradually towards the higher end of the E app distributions. We conclude that our results are inconsistent with a combination of monomers (or just donor-only dimers) and donor-acceptor dimers, and thus our proposal for mixtures of stable dimers and dynamic tetramers continues to stand.
The concept that a dimer may be the minimal in situ configuration of a GPCR is supported by recent work at a singleparticle level which concluded that the serotonin 5-HT 2C (5-hydroxytryptamine 2C) receptor is present as a dimer at the plasma membrane, but not as a monomer [40] . Notably, however, the same study was also unable to detect tetramers of this receptor. Furthermore, biochemical analysis of the organization of the orexin OX 1 receptor concluded that this GPCR also exists predominantly as a dimer [41] . Moreover, although an earlier single molecule-tracking study on the muscarinic M 1 receptor apparently identified monomer-dimer formation and dissociation [23] , these conclusions relied entirely on the view that the ligand used to label the receptor was monitoring monomerdimer transitions rather than, as suggested in the present study, potential dimer-tetramer transitions. If all class A GPCRs might be expected to show the same basic homo-oligomerization behaviour, the available data (i.e. presence against absence of tetramers) can be rationalized if receptor expression level in the serotonin 5-HT 2C receptor study [40] was substantially lower than in the present study and hence the proportion of dimers to tetramers may have been driven towards a predominance of dimers. This hypothesis could be tested if the overall expression level of the receptors was known in different studies. In the present study, the total concentration of donor-and acceptortagged receptors was ∼3×10 5 per cell (see the Results section).
The ligand does not significantly alter the relative abundance of dimers and tetramers
In addition to determining the quaternary structure of the M 3 R, we have also determined that selective agonist binding to any of the M 3 R forms did not have a significant effect on its structure and distribution among different oligomer sizes. Although this agrees with the findings of other similar studies ( [42] , and see [43] for a review) we cannot at this stage completely eliminate the possibility that ligands may affect the partition between dimers and tetramers under extreme concentration situations. To test this possibility will necessitate the use of rapid excitation switching to determine the total concentrations of receptors in the cells and a way to vary the total expression level of M 3 R over a broad range of concentrations. In addition, because agonist ligand binding to M 3 R is known to cause rapid conformational changes associated with receptor activation [36] , this may mean that the transmembrane domains that undergo conformational changes as a result of activation and those that are involved in protein-protein interface binding are distinct from one another. It has also been observed that the binding of an inverse agonist ligand to purified and reconstituted β 2 -adrenoceptors could modulate tetrameric organization [42] . Future studies should therefore attempt to probe such rapid alterations in quaternary structure.
A general framework for describing GPCR oligomerization
In summing up our observations above, we propose a general oligomeric structure model that is consistent with the results of the present study while also emphasizing some of the salient features of GPCR oligomeric structure as noted from the abundant literature. Our model ( Figure 5 ) assumes that there are two different binding sites on each receptor, each of which may be associated with a separate transmembrane domain or group of transmembrane domains. If the interaction between the dissimilar binding sites is much stronger than that between the similar binding sites, the monomers will associate first into stable dimers ( Figure 5A) ; then, the dimers may associate weakly (in comparison with protomers within dimers) to form tetramers with 'closed' structures, i.e. structures that cannot grow further ( Figure 5B ). In addition, these tetramers are predicted to take a rhombic shape ( Figure 5B ). As discussed above, the M 3 R appears to indeed present these features, i.e. it forms rhombus shaped tetramers, but not hexamers. If, by contrast, each binding site strongly interacts with the site of its own type but weakly with a dissimilar site, the dimers ( Figure 5C) can form 'open' tetramers ( Figure 5D ), i.e. tetramers that can grow into higher order oligomers by successive addition of dimers, as suggested initially by Lopez-Gimenez et al. [44] . An argument can also be made for the existence of a third possibility, which is in fact a particular case of the first two, that of indistinguishable binding sites. In this case, dimers and tetramers may coexist with monomers and trimers. Also in this case, whether the receptors may form oligomers with open or closed configurations may depend on secondary factors, such as additional non-specific interactions, concentration and temperature. In fact, these factors may also alter the degree of association between the two types of dimers illustrated in Figure 5 , but they would not be decisive with regard to whether the higher order oligomer has a closed or open structure.
Our proposal reconciles published experiments that report different oligomeric sizes or combinations thereof for different receptors and perhaps different expression levels. Further investigations are necessary in order to fully elucidate which receptor exactly falls into which category and also to identify the specific binding sites. Availability of atomic level crystal structures for greater numbers of receptors would provide a tremendous boost to wide-ranging efforts to determine the location of the binding interfaces on individual receptors. The structure of M 3 R has been determined recently [45] , and efforts are underway in various labs to determine the crystal structure of other GPCRs.
Only two clear examples identifying interfaces able to form dimers [10] and tetramers [11] as well as their orientation within the dimer/oligomer are currently available. The atomic level structure of the μ-opioid receptor illustrates the potential for dimeric-tetrameric exchange and that the extent of this might be defined by expression levels and local variations in receptor concentration, e.g. in distinct regions of the plasma membrane such as cholesterol-rich domains or rafts. The structure [11] shows a dimeric four-helix bundle interface provided by many of the residues of transmembrane domains V and VI. Such an extensive interface is likely to be highly stable and would provide a basis for the minimum organization of the receptor being a dimer. However, although clearly observed in the crystal structures, the second interface, provided by amino acids from transmembrane domains I and II and elements of helix 8, is much less extensive, and therefore intrinsically likely to be far less stable. This might well provide a molecular basis for our observations of the coexistence of dimers and tetramers of M 3 R within the plasma membrane and the potential for the proportion of each to be determined by receptor expression level. Even though in the current experiments the donor expression level was controlled by induction of expression of the energy donor species, we have not been able to control total expression level over a wide range to allow detailed analysis of this question, although it is noteworthy that the estimated proportion of dimers decreased as we increased the expression of the energy donor variant. Given that the M 3 R is expressed in high amounts in various smooth muscles and in certain regions of the brain, but at lower levels in tissues such as salivary gland and pancreatic β-cells [46] , it may be that the steady-state distribution between dimers and tetramers will vary in different cells and tissues.
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The muscarinic M 3 acetylcholine receptor exists as two differently sized complexes at the plasma membrane 
Estimation of the protein expression level
From the k DA and k AD values determined from spectral unmixing, we calculated the fluorescence of the donor in the absence of acceptor using the formula
A , where all the symbols are as defined in the main text. Then we calculated the average donor fluorescence in the absence of FRET. In order to obtain an order of magnitude estimate of the donor concentration inside the cells, we used the following expression, derived from the expression for the number of photons generated by a twophoton absorption process [1] : where C is the molar concentration, F is the average fluorescence intensity of the donors in the absence of energy transfer, σ is the two-photon absorption cross-section, Q is the quantum yield, td is the pixel dwell time of the scanning system, NA is the numerical aperture of the microscope objective, P is the average excitation light power, f is the repetition rate of the laser pulse, τ is the laser pulse duration (50 fs for the KM Labs laser used in the FRET study and 170 fs for the MaiTai TM laser used for concentration calibration, see below) and λ is the excitation wavelength, whereas the subscripts s and x stand for standard solution and for the unknown concentration (of donor-tagged molecules). The average fluorescence intensity of a fluorescent standard consisting of an aqueous solution of YFP (10 μM concentration) was determined using a separate microscope, Zeiss Axio Observer (Zeiss) equipped with an OptiMiS TM module (Aurora Spectral Technologies) and an ultrashort-pulse laser (MaiTai TM ; Spectra Physics) tuned to 960 nm. The solution of YFP was prepared as described previously [2] . The absorption cross sections and the quantum yields were obtained from the literature [3, 4] .
Using this method, we estimated the donor concentrations, which varied at 1.1-2.5×10 5 molecules per cell for doxycycline concentrations ranging 0.5-100 ng/ml. The ratios of donor to acceptor concentrations determined from fitting the bar chart of peak areas (see the main text) allowed us to then calculate the concentration of acceptors, which varied between 1. 
